ANDA vs NDA
ANDA is an abbreviated application for approving a generic version of an already approved drug, while NDA is a full application for approving a new drug that needs original safety and effectiveness evidence. This comparison clarifies the word “Abbreviated” in Abbreviated New Drug Application because ANDA does not start drug approval from zero; it depends on the approved drug that came before it. Generic Approval Route ANDA belongs to the generic approval route. A company uses it when the proposed medicine is not being introduced as a completely new drug but as a generic version of a product that already has regulatory approval. New Drug Approval Route NDA belongs to the new drug approval route. A company uses it when the medicine has not already been approved and needs original evidence to support its safety, effectiveness, quality, manufacturing, and proposed labeling. Evidence Difference The main difference is the type of evidence needed. ANDA focuses on proving that the ...